These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 18434849)

  • 1. Inhibition of experimental angiogenesis of cornea by various doses of doxycycline and combination of triamcinolone acetonide with low-molecular-weight heparin and doxycycline.
    Aydin E; Kivilcim M; Peyman GA; Esfahani MR; Kazi AA; Sanders DR
    Cornea; 2008 May; 27(4):446-53. PubMed ID: 18434849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of corneal neovascularization: evaluation of various commercially available compounds in an experimental rat model.
    Riazi-Esfahani M; Peyman GA; Aydin E; Kazi AA; Kivilcim M; Sanders DR
    Cornea; 2006 Aug; 25(7):801-5. PubMed ID: 17068457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of combinations of flurbiprofen, low molecular weight heparin, and doxycycline on the inhibition of corneal neovascularization.
    Peyman GA; Kazi AA; Riazi-Esfahani M; Aydin E; Kivilcim M; Sanders DR
    Cornea; 2006 Jun; 25(5):582-5. PubMed ID: 16783147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and treatment of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with corticosteroid in experimental rats.
    Hashemian MN; Moghimi S; Kiumehr S; Riazi M; Amoli FA
    Ophthalmic Res; 2009; 42(2):90-5. PubMed ID: 19546599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of corneal angiogenesis by ascorbic acid in the rat model.
    Peyman GA; Kivilcim M; Morales AM; DellaCroce JT; Conway MD
    Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1461-7. PubMed ID: 17318569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of subconjuctival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits.
    Kang S; Chung SK
    Cornea; 2010 Feb; 29(2):192-6. PubMed ID: 20098156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of topical thymoquinone on corneal neovascularization.
    Erdurmus M; Yagci R; Yilmaz B; Hepsen IF; Turkmen C; Aydin B; Karadag R
    Cornea; 2007 Jul; 26(6):715-9. PubMed ID: 17592323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitory effects of trastuzumab on corneal neovascularization.
    Güler M; Yilmaz T; Ozercan I; Elkiran T
    Am J Ophthalmol; 2009 Apr; 147(4):703-708.e2. PubMed ID: 19054498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibitory effect of different concentrations of topical bevacizumab on corneal neovascularization.
    Habot-Wilner Z; Barequet IS; Ivanir Y; Moisseiev J; Rosner M
    Acta Ophthalmol; 2010 Dec; 88(8):862-7. PubMed ID: 19549103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of oral doxycycline on neovascularization in a rat corneal alkali burn model of angiogenesis.
    Dan L; Shi-long Y; Miao-li L; Yong-ping L; Hong-jie M; Ying Z; Xiang-gui W
    Curr Eye Res; 2008 Aug; 33(8):653-60. PubMed ID: 18696340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin).
    Manzano RP; Peyman GA; Khan P; Carvounis PE; Kivilcim M; Ren M; Lake JC; Chévez-Barrios P
    Br J Ophthalmol; 2007 Jun; 91(6):804-7. PubMed ID: 17179168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of SU5416, a selective vascular endothelial growth factor receptor tyrosine kinase inhibitor, on experimental corneal neovascularization.
    Keskin U; Totan Y; Karadağ R; Erdurmuş M; Aydın B
    Ophthalmic Res; 2012; 47(1):13-8. PubMed ID: 21691137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A.
    Benelli U; Ross JR; Nardi M; Klintworth GK
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):274-82. PubMed ID: 9040459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of chemical cautery-induced corneal neovascularization by topical pigment epithelium-derived factor eyedrops.
    Jin J; Ma JX; Guan M; Yao K
    Cornea; 2010 Sep; 29(9):1055-61. PubMed ID: 20539216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical and subconjunctival bevacizumab for corneal neovascularization in an experimental rat model.
    Öner V; Küçükerdönmez C; Akova YA; Çolak A; Karalezli A
    Ophthalmic Res; 2012; 48(3):118-23. PubMed ID: 22538642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subconjunctival injection of low-molecular-weight heparin-taurocholate 7 inhibits corneal neovascularization.
    Yoon SY; Kim JY; Kim ES; Kim SY; Kim MJ; Tchah H
    Cornea; 2013 Nov; 32(11):1488-92. PubMed ID: 24055905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs.
    Hurmeric V; Mumcuoglu T; Erdurman C; Kurt B; Dagli O; Durukan AH
    Cornea; 2008 Apr; 27(3):357-62. PubMed ID: 18362668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with its topical form in experimental rats.
    Hashemian MN; Z-Mehrjardi H; Moghimi S; Tahvildari M; Mojazi-Amiri H
    Ophthalmic Res; 2011; 46(1):50-4. PubMed ID: 21212709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of subconjunctivally injected bevacizumab, etanercept, and the combination of both drugs on experimental corneal neovascularization.
    Ozdemir O; Altintas O; Altintas L; Yildiz DK; Sener E; Caglar Y
    Can J Ophthalmol; 2013 Apr; 48(2):115-20. PubMed ID: 23561605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-control study of subconjunctival triamcinolone acetonide injection vs intravenous methylprednisolone pulse in the treatment of endothelial corneal allograft rejection.
    Costa DC; de Castro RS; Kara-Jose N
    Eye (Lond); 2009 Mar; 23(3):708-14. PubMed ID: 18820657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.